The in vivo Pig-a assay: A report of the International Workshop On Genotoxicity Testing (IWGT) Workgroup.

The in vivo Pig-a assay uses flow cytometry to measure phenotypic variants for antibody binding to cell surface glycosylphosphatidylinositol (GPI)-anchored proteins. There is good evidence suggesting that the absence of antibody binding is the result of a mutation in the endogenous X-linked Pig-a gene, which forms the rationale for the assay. Although the assay has been performed with several types of hematopoietic cells and in a variety of mammalian species, including humans, currently it is optimized only for measuring CD59-deficient (presumed Pig-a mutant) erythrocytes in the peripheral blood of rats. An expert workgroup formed by the International Workshop on Genotoxicity Testing considered the state of assay development and the potential of the assay for regulatory use. Consensus was reached on what is known about the Pig-a assay and how it should be conducted, and recommendations were made on additional data and refinements that would help to further enhance the assay for use in hazard identification and risk assessment.

[1]  J. T. Macgregor,et al.  Interlaboratory Pig‐a gene mutation assay trial: Studies of 1,3‐propane sultone with immunomagnetic enrichment of mutant erythrocytes , 2011, Environmental and molecular mutagenesis.

[2]  V. Thybaud,et al.  Need and potential value of the Pig‐ain vivo mutation assay—A hesi perspective , 2011, Environmental and molecular mutagenesis.

[3]  A. A. Reilly,et al.  Relationships between exposure, cell loss and proliferation, and manifestation of Hprt mutant T cells following treatment of preweanling, weanling, and adult male mice with N-ethyl-N-nitrosourea. , 1999, Mutation research.

[4]  Y. Katsuura,et al.  Development of an in vivo gene mutation assay using the endogenous Pig‐A gene: I. Flow cytometric detection of CD59‐negative peripheral red blood cells and CD48‐negative spleen T‐cells from the rat , 2008, Environmental and molecular mutagenesis.

[5]  S. Dertinger,et al.  The in vivo pig‐a gene mutation assay, a potential tool for regulatory safety assessment , 2010, Environmental and molecular mutagenesis.

[6]  R. Mittelstaedt,et al.  Analysis of mutations in the Pig‐a gene of spleen T‐cells from N‐ethyl‐N‐nitrosourea‐treated fisher 344 rats , 2011, Environmental and molecular mutagenesis.

[7]  J. T. Macgregor,et al.  Efficient monitoring of in vivo pig-a gene mutation and chromosomal damage: summary of 7 published studies and results from 11 new reference compounds. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  M. Yamada,et al.  Interlaboratory trial of the rat Pig-a mutation assay using an erythroid marker HIS49 antibody. , 2013, Mutation research.

[9]  Lucio Luzzatto,et al.  The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo. , 2010, Mutation research.

[10]  R. Ware,et al.  Immunophenotypic analysis of reticulocytes in paroxysmal nocturnal hemoglobinuria. , 1995, Blood.

[11]  Satsuki Chikura,et al.  Effective use of the Pig-a gene mutation assay for mutagenicity screening: measuring CD59-deficient red blood cells in rats treated with genotoxic chemicals. , 2012, The Journal of toxicological sciences.

[12]  T. Lawlor,et al.  Integration of Pig‐a, micronucleus, chromosome aberration, and comet assay endpoints in a 28‐day rodent toxicity study with 4‐nitroquinoline‐1‐oxide , 2011, Environmental and molecular mutagenesis.

[13]  David Lovell,et al.  Compilation and use of genetic toxicity historical control data. , 2011, Mutation research.

[14]  M. Schuler,et al.  Evaluation of a modified CD71 MicroFlow method for the flow cytometric analysis of micronuclei in rat bone marrow erythrocytes. , 2010, Mutation research.

[15]  P. Kamoun,et al.  Novel nonsense mutation in the hypoxanthine guanine phosphoribosyltransferase gene and nonrandom X‐inactivation causing Lesch‐Nyhan syndrome in a female patient , 1996, Human mutation.

[16]  S. Nikfar,et al.  Organization for Economic Cooperation and Development (OECD) , 2014 .

[17]  J. Bemis,et al.  In vivo mutation assay based on the endogenous Pig‐a locus , 2008, Environmental and molecular mutagenesis.

[18]  J. T. Macgregor,et al.  Persistence of cisplatin-induced mutagenicity in hematopoietic stem cells: implications for secondary cancer risk following chemotherapy. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  Ollivier Hyrien,et al.  Pig-a mutation: kinetics in rat erythrocytes following exposure to five prototypical mutagens. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[20]  V. Rosti.  The molecular basis of paroxysmal nocturnal hemoglobinuria. , 2000, Haematologica.

[21]  M. Honma,et al.  Further development of the rat Pig‐a mutation assay: Measuring rat Pig‐a mutant bone marrow erythroids and a high throughput assay for mutant peripheral blood reticulocytes , 2011, Environmental and molecular mutagenesis.

[22]  A. Tates,et al.  An analysis of in vivo hprt mutant frequency in circulating T-lymphocytes in the normal human population: a comparison of four datasets. , 1994, Mutation research.

[23]  D. Miura.  The In Vivo Pig-a Gene Mutation Assay , 2014 .

[24]  T Sofuni,et al.  Report of the IWGT working group on strategy/interpretation for regulatory in vivo tests II. Identification of in vivo-only positive compounds in the bone marrow micronucleus test. , 2007, Mutation research.

[25]  S. Dertinger,et al.  When pigs fly: immunomagnetic separation facilitates rapid determination of Pig-a mutant frequency by flow cytometric analysis. , 2011, Mutation research.

[26]  J. T. Macgregor,et al.  International Pig‐a gene mutation assay trial: Evaluation of transferability across 14 laboratories , 2011, Environmental and molecular mutagenesis.

[27]  H. Schrezenmeier,et al.  The spectrum of PIG-A gene mutations in aplastic anemia/paroxysmal nocturnal hemoglobinuria (AA/PNH): a high incidence of multiple mutations and evidence of a mutational hot spot. , 2003, Blood.

[28]  I. Lambert,et al.  Detailed review of transgenic rodent mutation assays. , 2005, Mutation research.

[29]  L. Krsmanović,et al.  Assessment of genotoxicity induced by 7,12‐dimethylbenz(a)anthracene or diethylnitrosamine in the Pig‐a, micronucleus and Comet assays integrated into 28‐day repeat dose studies , 2011, Environmental and molecular mutagenesis.

[30]  J. T. Macgregor,et al.  Integration of mutation and chromosomal damage endpoints into 28-day repeat dose toxicology studies. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[31]  J. Shaddock,et al.  Sensitivity of the Pig-a assay for detecting gene mutation in rats exposed acutely to strong clastogens. , 2013, Mutagenesis.

[32]  T. Kinoshita,et al.  Defective glycosyl phosphatidylinositol anchor synthesis and paroxysmal nocturnal hemoglobinuria. , 1995, Advances in immunology.

[33]  R. Mittelstaedt,et al.  Evaluation of Macaca mulatta as a model for genotoxicity studies. , 2009, Mutation research.

[34]  F. D. de Serres,et al.  Specific-locus mutations induced in eukaryotes (especially mammalian cells) by radiation and chemicals: a perspective. , 1989, Mutation research.

[35]  A. Lynch,et al.  International Pig‐a gene mutation assay trial (Stage III): Results with N‐methyl‐N‐nitrosourea , 2011, Environmental and molecular mutagenesis.

[36]  J. Shaddock,et al.  7,12‐dimethylbenz[a]anthracene‐induced mutation in the Tk gene of Tk+/− mice: Automated scoring of lymphocyte clones using a fluorescent viability indicator , 2000, Environmental and molecular mutagenesis.

[37]  Mateos,et al.  Purine metabolism in female heterozygotes for hypoxanthine–guanine phosphoribosyltransferase deficiency , 1998, European journal of clinical investigation.

[38]  J. Bemis,et al.  Erythrocyte-based Pig-a gene mutation assay: demonstration of cross-species potential. , 2008, Mutation research.

[39]  W. Ding,et al.  Evaluating the weak in vivo micronucleus response of a genotoxic carcinogen, aristolochic acids. , 2013, Mutation research.

[40]  P. White,et al.  Simultaneous Measurement of Benzo[a]pyrene-induced Pig-a and lacZ Mutations, Micronuclei and DNA Adducts in Muta™ Mouse , 2011, Environmental and molecular mutagenesis.

[41]  J. Shaddock,et al.  Report on stage III Pig‐a mutation assays using benzo[a]pyrene , 2011, Environmental and molecular mutagenesis.

[42]  M. Schuler,et al.  Defining EMS and ENU dose-response relationships using the Pig-a mutation assay in rats. , 2011, Mutation research.

[43]  R. Heflich,et al.  Monitoring humans for somatic mutation in the endogenous pig‐a gene using red blood cells , 2011, Environmental and molecular mutagenesis.

[44]  M. Bishop,et al.  Flow cytometric detection of Pig‐A mutant red blood cells using an erythroid‐specific antibody: Application of the method for evaluating the in vivo genotoxicity of methylphenidate in adolescent rats , 2009, Environmental and molecular mutagenesis.

[45]  J. T. Macgregor,et al.  Diethylnitrosamine genotoxicity evaluated in sprague dawley rats using Pig‐a mutation and reticulocyte micronucleus assays , 2014, Environmental and molecular mutagenesis.

[46]  J. T. Macgregor,et al.  Pig‐a gene mutation and micronucleated reticulocyte induction in rats exposed to tumorigenic doses of the leukemogenic agents chlorambucil, thiotepa, melphalan, and 1,3‐propane sultone , 2014, Environmental and molecular mutagenesis.

[47]  S. Dertinger,et al.  In vivo assessment of Pig‐a gene mutation—recent developments and assay validation , 2011, Environmental and molecular mutagenesis.

[48]  R. Mittelstaedt,et al.  Development of an in vivo gene mutation assay using the endogenous Pig‐A gene: II. Selection of Pig‐A mutant rat spleen T‐cells with proaerolysin and sequencing Pig‐A cDNA from the mutants , 2008, Environmental and molecular mutagenesis.

[49]  S. Jhanwar,et al.  The spectrum of somatic mutations in the PIG-A gene in paroxysmal nocturnal hemoglobinuria includes large deletions and small duplications. , 1998, Blood cells, molecules & diseases.

[50]  M. Aardema,et al.  Integration of Pig-a, micronucleus, chromosome aberration and comet assay endpoints in a 28-day rodent toxicity study with urethane. , 2015, Mutagenesis.

[51]  L Luzzatto,et al.  Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Shaddock,et al.  Report on stage III Pig‐a mutation assays using N‐ethyl‐N‐nitrosourea – comparison with other in vivo genotoxicity endpoints , 2011, Environmental and molecular mutagenesis.

[53]  R. Heflich,et al.  Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea. , 2009, Mutation research.

[54]  R. Torres,et al.  Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome , 2007, Orphanet journal of rare diseases.

[55]  Vasily N Dobrovolsky,et al.  Manifestation of Pig-a mutant bone marrow erythroids and peripheral blood erythrocytes in mice treated with N-ethyl-N-nitrosourea: direct sequencing of Pig-a cDNA from bone marrow cells negative for GPI-anchored protein expression. , 2011, Mutation research.

[56]  J. Shaddock,et al.  Mutagenicity of γ‐radiation, mitomycin C, and etoposide in the Hprt and Tk genes of Tk+/− mice † , 2002 .

[57]  R. Mittelstaedt,et al.  Genotoxicity of furan in Big Blue rats. , 2012, Mutation research.

[58]  J. T. Macgregor,et al.  In vivo flow cytometric Pig‐a and micronucleus assays: Highly sensitive discrimination of the carcinogen/noncarcinogen pair benzo(a)pyrene and pyrene using acute and repeated‐dose designs , 2012, Environmental and molecular mutagenesis.

[59]  R. Ware,et al.  The molecular basis of paroxysmal nocturnal hemoglobinuria. , 1995, Blood.

[60]  J. Bhalli,et al.  Manifestation and persistence of Pig‐a mutant red blood cells in C57BL/6 mice following single and split doses of N‐ethyl‐N‐nitrosourea , 2011, Environmental and molecular mutagenesis.

[61]  T. Singer,et al.  Assessment of the genotoxic potential of azidothymidine in the comet, micronucleus, and Pig-a assay. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.